繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

OCGN、DNMR和DERM均为市前涨幅股

2024-03-26 20:33

  • Gainers: Stoke Therapeutics  (STOK) +95% Q4 earnings call release
  • Check-Cap  (CHEK) +47% jumps on Nobul AI business combination.
  • Mesoblast  (MESO) +30% gains as FDA backs regulatory plans for cell therapy.
  • Krispy Kreme  (DNUT) +23% plan to expand partnership across the U.S..
  • Trump Media & Technology Group  (DJT) +18% soars 20% ahead of Nasdaq debut today.
  • Praxis Precision Medicines  (PRAX) +19% Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients.
  • Invivyd  (IVVD) +18%.
  • Viking Therapeutics  (VKTX) +16% gains on early data for oral weight loss therapy.
  • Sutro Biopharma  (STRO) +15% FY earnings call release
  • X.T.L. Biopharmaceuticals  (XTLB) +13%.
  • Reddit  (RDDT) +11% roars back as shares jump 30% on Monday, adds more post-market.
  • Journey Medical  (DERM) +10%.
  • Forge Global Holdings  (FRGE) +8%.
  • Perimeter Solutions (PRM) +8%.
  • Cadeler  (CDLR) +8%.
  • Hempacco (HPCO) +8% partners with Gumbo Brands to launch cannabinoid-infused gummies.
  • Nuvation  (NUVB) +8% falls after AnHeart Therapeutics acquisition news.
  • Sunnova Energy International  (NOVA) +7% selected by Home Depot as exclusive solar, battery storage provider.
  • Biohaven Ltd (BHVN) +7% gains on early data for oral weight loss therapy.
  • Advantage Solutions  (ADV) +6%.
  • Ocugen  (OCGN) +6%.
  • Intelligent Group  (INTJ) +6%.
  • McCormick  (MKC) +6% trades higher after margins expand in Q1.
  • Danimer Scientific  (DNMR) +6%.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。